Literature DB >> 6429243

Regulation of natural killer cell activity by macrophages in the rheumatoid joint and peripheral blood.

B Combe, R Pope, B Darnell, W Kincaid, N Talal.   

Abstract

Recently, in another study, we observed that indomethacin, a prostaglandin synthetase inhibitor, significantly increased NK activity in both normal and rheumatoid arthritis (RA) peripheral blood (PB) but not in RA synovial fluid (SF). Because macrophages are a major source of prostaglandins, we examined the effect of macrophage-enriched adherent cells (AC) on NK activity as measured by a 3-hr Cr-release assay with K 562 cells. The removal of AC resulted in increased (p less than 0.01) NK activity in both normal and RA PB. In contrast, the removal of AC from RA SF resulted in a significant decrease (p less than 0.001) of NK activity. By using only nonadherent cells (NAC), NK activity in RA SF and synovial tissue (ST) was significantly reduced when compared to autologous RA PB (p less than 0.001). Enhancement of NK activity of SF NAC by both poly I:C and IL 2 was not dependent on AC. Mixing experiments demonstrated that the addition of synovial AC for 16 hr increased NK activity of synovial NAC to a level similar to that of unseparated mononuclear cells, whereas autologous PB AC suppressed NK activity of PB NAC. PB AC, when added to SF NAC, also increased NK activity. Supernatants from synovial mononuclear cells were stimulatory of synovial NAC NK activity, whereas normal PB mononuclear supernatants were suppressive. These observations document 1) a significant reduction of NAC-mediated NK activity in the rheumatoid joint as compared to PB from the same patient, and 2) that AC modulate NK activity differently in the rheumatoid joint as compared to RA or normal PB.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429243

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities.

Authors:  U Reinhold; W Wehrmann; S Kukel; H W Kreysel
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets.

Authors:  K N Masihi; W Lange; B Rohde-Schulz
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.

Authors:  B Combe; R M Pope; M Fischbach; B Darnell; S Baron; N Talal
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

4.  Defective mitogen-induced cellular cytotoxicity in untreated patients with active rheumatoid arthritis.

Authors:  G Vaiopoulos; D Kyriakou; H Papadaki; P Kaklamanis; G D Eliopoulos
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

5.  Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission.

Authors:  G Pizzolo; L Trentin; F Vinante; C Agostini; R Zambello; M Masciarelli; C Feruglio; F Dazzi; G Todeschini; M Chilosi
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

6.  Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes.

Authors:  K Oshimi; Y Oshimi; M Satake; H Mizoguchi
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.